CORE: Genetically Engineered Mouse Shared Resource (Cell and in vivo Biology Group) PROJECT SUMMARY The goal of the Genetically Engineered Mouse Shared Resource (GEM SR) is to assist Cancer Center Investigators with the design and execution of experiments to develop and utilize animal models for the investigation of the progression of cancer and preclinical evaluations of therapies for the treatment of cancer. The GEM SR facility began in 1987 as a Transgenic Mouse Core in the Center for Reproductive Research in the Department of Molecular and Cellular Biology. In 1996, it was adopted as an Institutional Core and changed its name to the Genetically Engineered Mouse Core with service restricted at that time to the generation of transgenic mice by microinjection of DNA into the pronucleus of the one-cell mouse embryo. As the field evolved, the GEM Core expanded its services to the most current production avenues for transgenic mouse models, as well as, the preservation and rederivation of transgenics for further use. The GEM facility is now a matrix Core co-managed and co-supported as an Institutional Advanced Technology Core (ATC) and as a Cancer Center Shared Resource. During the last funding period of the CCSG, the GEM SR incorporated improvements in sperm cryopreservation and in vitro fertilization and developed an efficient means of germline transmission of C57Bl/6N embryonic stem cells. Most recently for the current CCSG, we have initiated the new genome editing CRISPR/Cas approach. The GEM SR will continue to serve as a resource for the execution and training in the use of animal manipulations needed in the Cancer Center. This will minimize the cost of utilizing animal cancer models by consolidating the equipment, expertise, and animal resources required. The GEM SR will accomplish its goals by 1) generating transgenic mice of interest by traditional microinjection of DNA and/or RNA into the one-cell mouse embryo; 2) generating genetically engineered mice by targeting with genetically manipulated mouse embryonic stem cells; and 3) preserving transgenic mice through cryopreservation of mouse embryos and sperm.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA125123-10
Application #
9118145
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2016-07-01
Budget End
2017-06-30
Support Year
10
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Kundu, Samrat T; Grzeskowiak, Caitlin L; Fradette, Jared J et al. (2018) TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsins. Nat Commun 9:2731
Kim, Myunghoo; Galan, Carolina; Hill, Andrea A et al. (2018) Critical Role for the Microbiota in CX3CR1+ Intestinal Mononuclear Phagocyte Regulation of Intestinal T Cell Responses. Immunity 49:151-163.e5
Mamonkin, Maksim; Mukherjee, Malini; Srinivasan, Madhuwanti et al. (2018) Reversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-cell Malignancies. Cancer Immunol Res 6:47-58
Morriss, Ginny R; Rajapakshe, Kimal; Huang, Shixia et al. (2018) Mechanisms of skeletal muscle wasting in a mouse model for myotonic dystrophy type 1. Hum Mol Genet 27:2789-2804
Lanza, Denise G; Gaspero, Angelina; Lorenzo, Isabel et al. (2018) Comparative analysis of single-stranded DNA donors to generate conditional null mouse alleles. BMC Biol 16:69
Jeong, Mira; Park, Hyun Jung; Celik, Hamza et al. (2018) Loss of Dnmt3a Immortalizes Hematopoietic Stem Cells In Vivo. Cell Rep 23:1-10
Boudreaux, Seth P; Duren, Ryan P; Call, Steven G et al. (2018) Drug targeting of NR4A nuclear receptors for treatment of acute myeloid leukemia. Leukemia :
Sukumaran, Sujita; Watanabe, Norihiro; Bajgain, Pradip et al. (2018) Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment. Cancer Discov 8:972-987
Kaochar, Salma; Mitsiades, Nicholas (2018) A Novel Mechanism to Drive Castration-Resistant Prostate Cancer. Trends Endocrinol Metab 29:366-368
Johnston, A N; Bu, W; Hein, S et al. (2018) Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions. Breast Cancer Res 20:42

Showing the most recent 10 out of 991 publications